Harsanyi Zsolt 4
4 · Aptevo Therapeutics Inc. · Filed Jun 3, 2024
Insider Transaction Report
Form 4
Harsanyi Zsolt
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-02+81→ 280 total - Exercise/Conversion
Restricted Stock Unit
2024-06-02−81→ 0 total→ Common Stock (81 underlying) - Exercise/Conversion
Common Stock
2024-06-01+7→ 199 total - Exercise/Conversion
Restricted Stock Unit
2024-06-01−7→ 0 total→ Common Stock (7 underlying)
Footnotes (4)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F3]On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
- [F4]On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant.